Peter Hobart
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Immunology top 1%
- Immunotherapy and Immune Responses
Papers in
-
- RNA Interference and Gene Delivery 10
- vaccines and immunoinformatics approaches 10
- DNA and Nucleic Acid Chemistry 4
-
- Malaria Research and Control 14
- Mosquito-borne diseases and control 8
- Co-authors
- Richard C. Hedstrom (17 shared papers)Stephen L. Hoffman (15 shared papers)Martha Sedegah (13 shared papers)S L Hoffman (3 shared papers)Jon Norman (12 shared papers)Denise L. Doolan (12 shared papers)Yupin Charoenvit (8 shared papers)M Margalith (10 shared papers)
- Journals
- Human Gene Therapy (7 papers)Proceedings of the National Academy of Sciences (6 papers)Nature (4 papers)Vaccine (3 papers)Science (2 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Peter Hobart
52 papers receiving 4.5k citations
Peter Hobart's Hit Papers
Peers
Comparison fields: 5 of 106
- Virology 725
- Immunology 1.5k
- Infectious Diseases 930
- Molecular Biology 2.5k
- Public Health, Environmental and Occupational Health 869
Countries citing papers authored by Peter Hobart
This map shows the geographic impact of Peter Hobart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hobart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hobart more than expected).
Fields of papers citing papers by Peter Hobart
This network shows the impact of papers produced by Peter Hobart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hobart. The network helps show where Peter Hobart may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Hobart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Induction of Antigen-Specific Cytotoxic T Lymphocytes in Humans by a Malaria DNA Vaccine Hit paper breakdown → | 1998 | 648 |
| 2 | 1994 | 380 | |
| 3 | 1989 | 361 | |
| 4 | 1996 | 279 | |
| 5 | 1980 | 274 | |
| 6 | 1996 | 221 | |
| 7 | 1998 | 190 | |
| 8 | 2001 | 175 | |
| 9 | 2000 | 174 | |
| 10 | 1996 | 155 | |
| 11 | Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma. | 2002 | 141 |
| 12 | 1984 | 120 | |
| 13 | 1999 | 111 | |
| 14 | 2000 | 106 | |
| 15 | 1999 | 106 | |
| 16 | 1992 | 102 | |
| 17 | 2004 | 96 | |
| 18 | 1989 | 95 | |
| 19 | 1997 | 90 | |
| 20 | 1984 | 89 |
About Peter Hobart
Peter Hobart is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, Virology, Immunology and Genetics, having authored 53 papers that have together received 4.7k indexed citations. Recurring topics across this work include Malaria Research and Control (14 papers), RNA Interference and Gene Delivery (10 papers), HIV Research and Treatment (10 papers), vaccines and immunoinformatics approaches (10 papers), Mosquito-borne diseases and control (8 papers), Virus-based gene therapy research (7 papers), Immunotherapy and Immune Responses (6 papers) and DNA and Nucleic Acid Chemistry (4 papers). The work is most often cited by research in Virology (725 citations), Immunology (1.5k citations), Infectious Diseases (930 citations), Molecular Biology (2.5k citations) and Public Health, Environmental and Occupational Health (869 citations). Peter Hobart has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Richard C. Hedstrom, Stephen L. Hoffman, Martha Sedegah, S L Hoffman, Jon Norman, Denise L. Doolan, Yupin Charoenvit, M Margalith, M Sedegah and Trevor R. Jones. Their work appears in journals such as Human Gene Therapy, Proceedings of the National Academy of Sciences, Nature, Vaccine and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.